Theriva Biologics TOVX
NYSE TOVX
$0.24 +0.01 (+4.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Theriva Biologics (TOVX) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Theriva Biologics' Depreciation & Amortization (CF) was $24,000 in Q2 2026, down 11.1% from $27,000 a year earlier and unchanged from the prior quarter.

Analysis

Theriva Biologics (TOVX) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Theriva Biologics' Depreciation & Amortization (CF) was $103,000 through Jun 30, 2026, down 8.8% year-over-year; for FY2025, it came in at $108,000, down 21.2% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $137,000 in FY2024 (+1.5%), $135,000 in FY2023 (+58.8%), $85,000 in FY2022 (-2.3%) and $87,000 in FY2021 (-56.7%).
  • Quarterly Depreciation & Amortization (CF) has moved between $13,000 (Q4 2021) and $39,000 (Q1 2024) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in 1 of the last eight quarters, with an average decline of 15.5%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2022 (growth of 92.3%); the worst was Q3 2021 (a decline of 66.0%).
  • Per Business Quant data, TOVX's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $24,000 (Q1 2026), $27,000 (Q4 2025) and $28,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Theriva Biologics 11.01 Mn 11.01 Mn - 24,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24,000.00
Mar 31, 2026 24,000.00
Dec 31, 2025 27,000.00
Sep 30, 2025 28,000.00
Jun 30, 2025 27,000.00
Mar 31, 2025 26,000.00
Dec 31, 2024 27,000.00
Sep 30, 2024 33,000.00
Jun 30, 2024 38,000.00
Mar 31, 2024 39,000.00
Dec 31, 2023 39,000.00
Sep 30, 2023 32,000.00
Jun 30, 2023 32,000.00
Mar 31, 2023 32,000.00
Dec 31, 2022 25,000.00
Sep 30, 2022 24,000.00
Jun 30, 2022 18,000.00
Mar 31, 2022 18,000.00
Dec 31, 2021 13,000.00
Sep 30, 2021 18,000.00
API Access

Theriva Biologics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TOVX&period=max&api_key=YOUR_API_KEY